Prime Global, a recognised global leader in medical communications and market access, is continuing its sector-leading growth trajectory by securing investment from Levine Leichtman Capital Partners (LLCP), a leading global private equity firm.
Prime Global has experienced exceptional growth in recent years, including the recent launches of new consultancies Prime Access, IRIS, and Prime Omics, as well as the acquisition of Cambridge Medical Communication in May 2020. The company has also featured in both the Sunday Times Fast Track 100 and the top ten of the Alantra Fast Pharma 50 for three years running.
Graeme Peterson, CEO of Prime Global, says, “Prime Global is committed to helping our clients transform global health and patient outcomes, now and for future generations. We were looking for a partner to share this vision and match our people-first culture, and we’ve found that in LLCP. Their expertise and investment will allow us to develop additional capabilities, platforms, and tools to deliver more value for our people, clients, and ultimately, patients.”
LLCP is a leading global private equity firm with nearly four decades of experience partnering with ambitious management teams to provide further investment and support in accelerating growth. “We are thrilled to partner with Prime Global and look forward to supporting their continued success,” says John O’Neill, Head of Europe at LLCP, “With Prime Global’s strong leadership, ambitious strategic growth plans, and great market position, the future looks exciting!”
Jamie Austin, BDO M&A Partner, added, “This is a brilliant deal for both parties, powering Prime Global’s wonderful team and platform with funding and the international strength of LLCP. We are delighted to be part of the success, it is what BDO was set up to do.”
Prime Global and its shareholders were advised by BDO LLP (M&A Corporate Finance and Due Diligence), led by Jamie Austin and Rob McCann, and Addleshaw Goddard LLP (Legal), led by Paul Medlicott and George Danczak.